The trademark Macu-Vision was filed by Oak Pharma BV, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 28, 2021, and received one opposition filed on July 28, 2021 by OmniVision GmbH on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by LORENZ SEIDLER GOSSEL RECHTSANWÄLTE PATENTANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 28, 2021
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
A transfer of the trademark registration was recorded on May 17, 2022.
The Appeal with reference B R1394/2023-4 was Opposition allowed according to Article 8(1)(b) EUTMR with decision issued on April 29, 2024 by the EUIPO. The Opposition with reference B 003151764 was refused according to Article 8(1)(b) EUTMR with decision issued on May 9, 2023 by the EUIPO.